CCR5 and neoplasm: Similarly, CCL5, which promotes CCR5-mediated CD8+ T cell infiltration to the primary tumor site [27], was upregulated in MOC2, SCC83, and CAL27, but not LY2 HNSCC cells (Figure 2A–D).